Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012 (2012), Article ID 315918, 11 pages
http://dx.doi.org/10.1155/2012/315918
Review Article

Lung Cancer and Interstitial Lung Diseases: A Systematic Review

1Department of Pneumonology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece
2Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece

Received 12 March 2012; Revised 29 May 2012; Accepted 1 June 2012

Academic Editor: Edwin Chilvers

Copyright © 2012 Kostas Archontogeorgis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Raghu, F. Nyberg, and G. Morgan, “The epidemiology of interstitial lung disease and its association with lung cancer,” British Journal of Cancer, vol. 91, no. 2, pp. S3–S10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. T. Greenlee, M. B. Hill-Harmon, T. Murray, and M. Thun, “Cancer Statistics, 2001,” CA: A Cancer Journal for Clinicians, vol. 51, no. 1, pp. 15–36, 2001. View at Google Scholar · View at Scopus
  3. G. Friedrich, “Periphere Lungenkrebse auf dem Bodem pleuranaher,” Virchow's Archiv. Pathologische Anatomie, pp. 230–246, 1939. View at Google Scholar
  4. F. Drakopanagiotakis, A. Xifteri, V. Polychronopoulos, and D. Bouros, “Apoptosis in lung injury and fibrosis,” European Respiratory Journal, vol. 32, no. 6, pp. 1631–1638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Takahashi, T. Nukiwa, and R. Matsuoka, “Carcinoembryonic antigen in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis,” Japanese Journal of Medicine, vol. 24, no. 3, pp. 236–243, 1985. View at Google Scholar · View at Scopus
  6. K. Charalabopoulos, A. Karakosta, G. Bablekos et al., “CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers,” Medical Oncology, vol. 24, no. 2, pp. 219–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. C. Willis and Z. Borok, “Epithelial-mesenchymal transition: potential role in obliterative bronchiolitis?” Thorax, vol. 64, no. 9, pp. 742–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. C. Radisky, P. A. Kenny, and M. J. Bissell, “Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?” Journal of Cellular Biochemistry, vol. 101, no. 4, pp. 830–839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Wellner, J. Schubert, U. C. Burk et al., “The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs,” Nature cell biology, vol. 11, no. 12, pp. 1487–1495, 2009. View at Google Scholar · View at Scopus
  10. K. V. Pandit, D. Corcoran, H. Yousef et al., “Inhibition and role of let-7d in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 2, pp. 220–229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. J. Gross and G. W. Hunninghake, “Idiopathic pulmonary fibrosis,” New England Journal of Medicine, vol. 345, no. 7, pp. 517–525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kuwano, R. Kunitake, M. Kawasaki et al., “p21(Waf1/Cip1/Sdi1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 2, pp. 477–483, 1996. View at Google Scholar · View at Scopus
  13. D. A. Vassilakis, G. Sourvinos, D. A. Spandidos, N. M. Siafakas, and D. Bouros, “Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3 I, pp. 1115–1119, 2000. View at Google Scholar · View at Scopus
  14. K. Uematsu, A. Yoshimura, A. Gemma et al., “Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis,” Cancer Research, vol. 61, no. 23, pp. 8527–8533, 2001. View at Google Scholar · View at Scopus
  15. M. E. Froudarakis, G. Sourvinos, P. Fournel et al., “Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer,” Chest, vol. 113, no. 4, pp. 1091–1094, 1998. View at Google Scholar · View at Scopus
  16. A. S. Wilson, B. E. Power, and P. L. Molloy, “DNA hypomethylation and human diseases,” Biochimica et Biophysica Acta, vol. 1775, no. 1, pp. 138–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. I. Rabinovich, M. G. Kapetanaki, and I. Steinfeld, “Global methylation patterns in idiopathic pulmonary fibrosis,” PLoS One, vol. 7, Article ID e33770, 2012. View at Publisher · View at Google Scholar
  18. I. Fernandez-Garcia, C. Ortiz-De-Solorzano, and L. M. Montuenga, “Telomeres and telomerase in lung cancer,” Journal of Thoracic Oncology, vol. 3, no. 10, pp. 1085–1088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. D. Tsakiri, J. T. Cronkhite, P. J. Kuan et al., “Adult-onset pulmonary fibrosis caused by mutations in telomerase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 18, pp. 7552–7557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. K. Alder, J. D. Cogan, A. F. Brown et al., “Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis,” PLoS Genetics, vol. 7, no. 3, Article ID e1001352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. T. Cronkhite, C. Xing, G. Raghu et al., “Telomere shortening in familial and sporadic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 7, pp. 729–737, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, P. J. Kuan, C. Xing et al., “Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer,” American Journal of Human Genetics, vol. 84, no. 1, pp. 52–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Nagai, A. Chiyotani, T. Nakadate, and K. Konno, “Lung cancer in patients with idiopathic pulmonary fibrosis,” Tohoku Journal of Experimental Medicine, vol. 167, no. 3, pp. 231–237, 1992. View at Google Scholar · View at Scopus
  24. J. Park, D. S. Kim, T. S. Shim et al., “Lung cancer in patients with idiopathic pulmonary fibrosis,” European Respiratory Journal, vol. 17, no. 6, pp. 1216–1219, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Aubry, J. L. Myers, W. W. Douglas et al., “Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis,” Mayo Clinic Proceedings, vol. 77, no. 8, pp. 763–770, 2002. View at Google Scholar · View at Scopus
  26. I. Le Jeune, J. Gribbin, J. West, C. Smith, P. Cullinan, and R. Hubbard, “The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK,” Respiratory Medicine, vol. 101, no. 12, pp. 2534–2540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Wells and D. M. Mannino, “Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991,” Southern Medical Journal, vol. 89, no. 5, pp. 505–510, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Bouros, K. Hatzakis, H. Labrakis, and K. Zeibecoglou, “Association of malignancy with diseases causing interstitial pulmonary changes,” Chest, vol. 121, no. 4, pp. 1278–1289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Mizushima and M. Kobayashi, “Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis: a review of Japanese cases,” Chest, vol. 108, no. 5, pp. 1272–1277, 1995. View at Google Scholar · View at Scopus
  30. M. Turner-Warwick, M. Lebowitz, B. Burrows, and A. Johnson, “Cryptogenic fibrosing alveolitis and lung cancer,” Thorax, vol. 35, no. 7, pp. 496–499, 1980. View at Google Scholar · View at Scopus
  31. H. Brincker and E. Wilbek, “The incidence of malignant tumours in patients with sarcoidosis,” Ugeskrift for Laeger, vol. 136, no. 39, pp. 2192–2195, 1974. View at Google Scholar · View at Scopus
  32. M. Yamaguchi, M. Odaka, Y. Hosoda, K. Iwai, and T. Tachibana, “Excess death of lung cancer among sarcoidosis patients,” Sarcoidosis, vol. 8, no. 1, pp. 51–55, 1991. View at Google Scholar · View at Scopus
  33. J. Askling, J. Grunewald, A. Eklund, G. Hillerdal, and A. Ekbom, “Increased risk for cancer following sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5 I, pp. 1668–1672, 1999. View at Google Scholar · View at Scopus
  34. N. Seersholm, J. Vestbo, and K. Viskum, “Risk of malignant neoplasms in patients with pulmonary sarcoidosis,” Thorax, vol. 52, no. 10, pp. 892–894, 1997. View at Google Scholar · View at Scopus
  35. P. Boffetta, C. S. Rabkin, and G. Gridley, “A cohort study of cancer among sarcoidosis patients,” International Journal of Cancer, vol. 124, no. 11, pp. 2697–2700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. K. Rømer, P. Hommelgaard, and G. Schou, “Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients,” European Respiratory Journal, vol. 12, no. 4, pp. 906–912, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Marschke, “Sarcoidosis and malignant neoplasm: the Mayo Clinic experience,” Sarcoidosis, vol. 3, pp. 149–150, 1986. View at Google Scholar
  38. D. Valeyre, P. Soler, C. Clerici et al., “Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease,” Thorax, vol. 43, no. 7, pp. 516–524, 1988. View at Google Scholar · View at Scopus
  39. R. A. Harf, C. Ethevenaux, and J. Gleize, “Reduced prevalence of smokers in sarcoidosis: results of a case-control study,” Annals of the New York Academy of Sciences, vol. 465, pp. 625–631, 1986. View at Google Scholar · View at Scopus
  40. T. Peros-Golubicić and S. Ljubić, “Cigarette smoking and sarcoidosis,” Acta medica Croatica, vol. 49, no. 4-5, pp. 187–193, 1995. View at Google Scholar · View at Scopus
  41. D. Gupta, A. D. Singh, R. Agarwal, A. N. Aggarwal, K. Joshi, and S. K. Jindal, “Is tobacco smoking protective for sarcoidosis? A case-control study from North India,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 27, no. 1, pp. 19–26, 2010. View at Google Scholar · View at Scopus
  42. H. Yamasawa, Y. Ishii, and S. Kitamura, “Concurrence of sarcoidosis and lung cancer. A report of four cases,” Respiration, vol. 67, no. 1, pp. 90–93, 2000. View at Google Scholar · View at Scopus
  43. J. Zatuchni, W. N. Campbell, and C. J. Zarafonetis, “Pulmonary fibrosis and terminal bronchiolar (alveolar-cell) carcinoma in scleroderma,” Cancer, vol. 6, pp. 1147–1158, 1953. View at Google Scholar
  44. J. Le Pavec, D. Launay, S. C. Mathai, P. M. Hassoun, and M. Humbert, “Scleroderma lung disease,” Clinical Reviews in Allergy and Immunology, vol. 40, no. 2, pp. 104–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Marasini, L. Conciato, L. Belloli, and M. Massarotti, “Systemic sclerosis and cancer,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 3, pp. 573–578, 2009. View at Google Scholar · View at Scopus
  46. K. B. Highland, M. C. Garin, and K. K. Brown, “The spectrum of scleroderma lung disease,” Seminars in Respiratory and Critical Care Medicine, vol. 28, no. 4, pp. 418–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Y. Kang, H. W. Yim, I. J. Kim et al., “Incidence of cancer among patients with systemic sclerosis in Korea results from a single centre,” Scandinavian Journal of Rheumatology, vol. 38, no. 4, pp. 299–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. C. L. Hill, A. M. Nguyen, D. Roder, and P. Roberts-Thomson, “Risk of cancer inpatients with scleroderma: a population based cohort study,” Annals of the Rheumatic Diseases, vol. 62, no. 8, pp. 728–731, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Chatterjee, G. W. Dombi, R. K. Severson, and M. D. Mayes, “Risk of malignancy in scleroderma: a population-based cohort study,” Arthritis and Rheumatism, vol. 52, no. 8, pp. 2415–2424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. T. N. Adžić, D. P. Pešut, L. M. Nagorni-Obradović, J. M. Stojšić, M. D. Vasiljević, and D. Bouros, “Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study,” Respiratory Medicine, vol. 102, no. 4, pp. 620–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Kanaji, J. Fujita, S. Bandoh et al., “Small cell lung cancer associated with systemic sclerosis,” Internal Medicine, vol. 44, no. 4, pp. 315–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Hesselstrand, A. Scheja, and A. Åkesson, “Mortality and causes of death in a Swedish series of systemic sclerosis patients,” Annals of the Rheumatic Diseases, vol. 57, no. 11, pp. 682–686, 1998. View at Google Scholar · View at Scopus
  53. A. K. Rosenthal, J. K. McLaughlin, G. Gridley, and O. Nyren, “Incidence of cancer among patients with systemic sclerosis,” Cancer, vol. 76, pp. 910–914, 1995. View at Google Scholar
  54. R. K. Winkelmann, D. B. Flach, and K. K. Unni, “Lung cancer and scleroderma,” Archives of Dermatological Research, vol. 280, pp. S15–S18, 1988. View at Google Scholar · View at Scopus
  55. M. Abu-Shakra, F. Guillemin, and P. Lee, “Cancer in systemic sclerosis,” Arthritis and Rheumatism, vol. 36, no. 4, pp. 460–464, 1993. View at Google Scholar · View at Scopus
  56. A. D. Roumm and T. A. Medsger JR., “Cancer and systemic sclerosis. An epidemiologic study,” Arthritis and Rheumatism, vol. 28, no. 12, pp. 1336–1340, 1985. View at Google Scholar · View at Scopus
  57. X. Kyndt, M. Hebbar, V. Queyrel, E. Hachulla, P. Y. Hatron, and B. Devulder, “Systemic sclerosis and malignancy: assessment of risk factors associated with the development of cancer in 123 patients with systemic sclerosis,” Revue de Medecine Interne, vol. 18, no. 7, pp. 528–532, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. E. K. Pontifex, C. L. Hill, and P. Roberts-Thomson, “Risk factors for lung cancer in patients with scleroderma: a nested case-control study,” Annals of the Rheumatic Diseases, vol. 66, no. 4, pp. 551–553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Buchbinder and C. L. Hill, “Malignancy in patients with inflammatory myopathy,” Current rheumatology reports, vol. 4, no. 5, pp. 415–426, 2002. View at Google Scholar · View at Scopus
  60. M. Gabrilovich, M. Raza, S. Dolan, and T. Raza, “Paraneoplastic polymyositis associated with squamous cell carcinoma of the lung,” Chest, vol. 129, no. 6, pp. 1721–1723, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. L. Huang, Y. J. Chen, M. W. Lin et al., “Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study,” British Journal of Dermatology, vol. 161, no. 4, pp. 854–860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Zhang, S. P. Jiang, and L. Huang, “Dermatomyositis and malignancy: a retrospective study of 115 cases,” European Review for Medical and Pharmacological Sciences, vol. 13, no. 2, pp. 77–80, 2009. View at Google Scholar · View at Scopus
  63. C. L. Hill, Y. Zhang, B. Sigurgeirsson et al., “Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study,” Lancet, vol. 357, no. 9250, pp. 96–100, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. B. B. Antiochos, L. A. Brown, Z. Li, T. D. Tosteson, R. L. Wortmann, and W. F. C. Rigby, “Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA,” Journal of Rheumatology, vol. 36, no. 12, pp. 2704–2710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Fujita, M. Tokuda, S. Bandoh et al., “Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature,” Rheumatology International, vol. 20, no. 2, pp. 81–84, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. W. H. Chow, G. Gridley, L. Mellemkjar, J. K. Mclaughlin, J. H. Olsen, and J. F. Fraumeni, “Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark,” Cancer Causes and Control, vol. 6, no. 1, pp. 9–13, 1995. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Yamada, A. Nakajima, E. Inoue et al., “Incidence of malignancy in Japanese patients with rheumatoid arthritis,” Rheumatology International, vol. 31, pp. 1487–1492, 2011. View at Google Scholar
  68. A. Parikh-Patel, R. H. White, M. Allen, and R. Cress, “Risk of cancer among rheumatoid arthritis patients in California,” Cancer Causes and Control, vol. 20, no. 6, pp. 1001–1010, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Khurana, R. Wolf, S. Berney, G. Caldito, S. Hayat, and S. M. Berney, “Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans,” Journal of Rheumatology, vol. 35, no. 9, pp. 1704–1708, 2008. View at Google Scholar · View at Scopus
  70. N. Takayanagi, D. Tokunaga, Y. Tsuchiya et al., “Lung cancer associated with rheumatoid arthritis and usual interstitial pneumonia,” Nihon Kokyūki Gakkai Zasshi, vol. 46, no. 6, pp. 438–442, 2008. View at Google Scholar · View at Scopus
  71. A. L. Smitten, T. A. Simon, M. C. Hochberg, and S. Suissa, “A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis,” Arthritis Research and Therapy, vol. 10, no. 2, article no. R45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Abásolo, E. Júdez, M. Á. Descalzo, I. González-Álvaro, J. A. Jover, and L. Carmona, “Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population,” Seminars in Arthritis and Rheumatism, vol. 37, no. 6, pp. 388–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Thomas, D. H. Brewster, R. J. Black, and G. J. Macfarlane, “Risk of malignancy among patients with rheumatic conditions,” International Journal of Cancer, vol. 88, pp. 497–502, 2000. View at Google Scholar
  74. L. Mellemkjaer, M. S. Linet, G. Gridley, M. Frisch, H. Møller, and J. H. Olsen, “Rheumatoid arthritis and risk of cancer,” Ugeskrift for Laeger, vol. 160, no. 21, pp. 3069–3073, 1998. View at Google Scholar · View at Scopus
  75. L. Mellemkjær, M. S. Linet, G. Gridley, M. Frisch, H. Møller, and J. H. Olsen, “Rheumatoid arthritis and cancer risk,” European Journal of Cancer Part A, vol. 32, no. 10, pp. 1753–1757, 1996. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Bernatsky, R. Ramsey-Goldman, and A. E. Clarke, “Malignancy in systemic lupus erythematosus: what have we learned?” Best Practice and Research: Clinical Rheumatology, vol. 23, no. 4, pp. 539–547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Bin, S. Bernatsky, C. Gordon et al., “Lung cancer in systemic lupus erythematosus,” Lung Cancer, vol. 56, no. 3, pp. 303–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Bernatsky, J. F. Boivin, L. Joseph et al., “An international cohort study of cancer in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 5, pp. 1481–1490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. O. Ragnarsson, G. Grondal, and K. Steinsson, “Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus,” Lupus, vol. 12, no. 9, pp. 687–691, 2003. View at Google Scholar · View at Scopus
  80. L. Bjornadal, B. Lofstrom, L. Yin, I. E. Lundberg, and A. Ekbom, “Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus,” Scandinavian Journal of Rheumatology, vol. 31, no. 2, pp. 66–71, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Ramsey-Goldman, S. A. Mattai, E. Schilling et al., “Increased risk of malignancy in patients with systemic lupus erythematosus,” Journal of Investigative Medicine, vol. 46, no. 5, pp. 217–222, 1998. View at Google Scholar · View at Scopus
  82. L. Mellemkjaer, V. Andersen, M. S. Linet, G. Gridley, and R. Hoover, “Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 4, pp. 761–768, 1997. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Kiyohara, M. Washio, T. Horiuchi et al., “Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population,” Lupus, vol. 18, no. 7, pp. 630–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Hubbard, A. Venn, S. Lewis, and J. Britton, “Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 5–8, 2000. View at Google Scholar · View at Scopus
  85. S. Bernatsky, L. Joseph, J. F. Boivin et al., “The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study,” Annals of the Rheumatic Diseases, vol. 67, no. 1, pp. 74–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. P. A. Hessel, J. F. Gamble, and M. Nicolich, “Relationship between silicosis and smoking,” Scandinavian Journal of Work, Environment and Health, vol. 29, no. 5, pp. 329–336, 2003. View at Google Scholar · View at Scopus
  87. F. Spigno, V. Mortara, V. Vitto, M. Biagioli, and F. Traversa, “Lung cancer in subjects suffering from silicosis in the Province of Genoa from 1979 to 2004,” Giornale Italiano di Medicina del Lavoro ed Ergonomia, vol. 29, no. 4, pp. 898–902, 2007. View at Google Scholar · View at Scopus
  88. J. C. Amabile, K. Leuraud, B. Vacquier, S. Caër-Lorho, A. Acker, and D. Laurier, “Multifactorial study of the risk of lung cancer among French uranium miners: radon, smoking and silicosis,” Health Physics, vol. 97, no. 6, pp. 613–621, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Tsuda, Y. Mino, A. Babazono et al., “A case-control study of lung cancer in relation to silica exposure and silicosis in a rural area in Japan,” Annals of Epidemiology, vol. 12, no. 5, pp. 288–294, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. M. M. Finkelstein, “Silica, silicosis, and lung cancer: a risk assessment,” American Journal of Industrial Medicine, vol. 38, pp. 8–18, 2000. View at Publisher · View at Google Scholar
  91. J. M. Hughes, H. Weill, R. J. Rando, R. Shi, A. D. McDonald, and J. C. McDonald, “Cohort mortality study of North American industrial sand workers. II. Case-referent analysis of lung cancer and silicosis deaths,” Annals of Occupational Hygiene, vol. 45, no. 3, pp. 201–207, 2001. View at Google Scholar · View at Scopus
  92. K. Steenland and W. Sanderson, “Lung cancer among industrial sand workers exposed to crystalline silica,” American Journal of Epidemiology, vol. 153, no. 7, pp. 695–703, 2001. View at Publisher · View at Google Scholar · View at Scopus
  93. J. C. McDonald, A. D. McDonald, J. M. Hughes, R. J. Rando, and H. Weill, “Mortality from lung and kidney disease in a cohort of North American industrial sand workers: an update,” Annals of Occupational Hygiene, vol. 49, no. 5, pp. 367–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Marinaccio, A. Scarselli, G. Gorini et al., “Retrospective mortality cohort study of Italian workers compensated for silicosis,” Occupational and Environmental Medicine, vol. 63, no. 11, pp. 762–765, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Berry, A. Rogers, and P. Yeung, “Silicosis and lung cancer: a mortality study of compensated men with silicosis in New South Wales, Australia,” Occupational Medicine, vol. 54, no. 6, pp. 387–394, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Kurihara and O. Wada, “Silicosis and smoking strongly increase lung cancer risk in silica-exposed workers,” Industrial Health, vol. 42, no. 3, pp. 303–314, 2004. View at Google Scholar · View at Scopus
  97. Y. Lacasse, S. Martin, S. Simard, and M. Desmeules, “Meta-analysis of silicosis and lung cancer,” Scandinavian Journal of Work, Environment and Health, vol. 31, no. 6, pp. 450–458, 2005. View at Google Scholar · View at Scopus
  98. C. Pelucchi, E. Pira, G. Piolatto, M. Coggiola, P. Carta, and C. La Vecchia, “Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996–2005,” Annals of Oncology, vol. 17, no. 7, pp. 1039–1050, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Maeda, Y. Nishimura, N. Kumagai et al., “Dysregulation of the immune system caused by silica and asbestos,” Journal of Immunotoxicology, vol. 7, no. 4, pp. 268–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Otsuki, M. Maeda, S. Murakami et al., “Immunological effects of silica and asbestos,” Cellular & molecular immunology, vol. 4, no. 4, pp. 261–268, 2007. View at Google Scholar · View at Scopus
  101. A. Gambelunghe, C. Antognelli, C. Del Buono et al., “Crystalline silica can induce oxidative stress by inhibiting glyoxalase system in bronchial epithelial cells,” Giornale Italiano di Medicina del Lavoro ed Ergonomia, vol. 29, no. 3, pp. 397–399, 2007. View at Google Scholar · View at Scopus
  102. C. Fanizza, C. L. Ursini, E. Paba et al., “Cytotoxicity and DNA-damage in human lung epithelial cells exposed to respirable α-quartz,” Toxicology in Vitro, vol. 21, no. 4, pp. 586–594, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. L. Wang, L. Bowman, Y. Lu et al., “Essential role of p53 in silica-induced apoptosis,” American Journal of Physiology, Lung Cellular and Molecular Physiology, vol. 288, no. 3, pp. L488–L496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. B. Liu, R. Guan, P. Zhou et al., “A distinct mutational spectrum of p53 and K-ras genes in lung cancer of workers with silicosis,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 19, no. 1-2, pp. 1–7, 2000. View at Google Scholar · View at Scopus
  105. S. Umemura, N. Fujimoto, A. Hiraki et al., “Aberrant promoter hypermethylation in serum DNA from patients with silicosis,” Carcinogenesis, vol. 29, no. 9, pp. 1845–1849, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Strand, J. I. Martinsen, V. F. Koefoed, J. Sommerfelt-Pettersen, and T. K. Grimsrud, “Asbestos-related cancers among 28,300 military servicemen in the Royal Norwegian Navy,” American Journal of Industrial Medicine, vol. 53, no. 1, pp. 64–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Loomis, J. M. Dement, S. H. Wolf, and D. B. Richardson, “Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers,” Occupational and Environmental Medicine, vol. 66, no. 8, pp. 535–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. A. H. Harding, A. Darnton, J. Wegerdt, and D. McElvenny, “Mortality among British asbestos workers undergoing regular medical examinations (1971–2005),” Occupational and Environmental Medicine, vol. 66, no. 7, pp. 487–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Bertolotti, D. Ferrante, D. Mirabelli et al., “Mortality in the cohort of the asbestos cement workers in the Eternit plant in Casale Monferrato (Italy),” Epidemiologia e prevenzione, vol. 32, no. 4-5, pp. 218–228, 2008. View at Google Scholar · View at Scopus
  110. F. Zhong, E. Yano, Z. M. Wang, M. Z. Wang, and Y. J. Lan, “Cancer mortality and asbestosis among workers in an asbestos plant in Chongqing, China,” Biomedical and Environmental Sciences, vol. 21, no. 3, pp. 205–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. B. W. Lee, J. C. Wain, K. T. Kelsey, J. K. Wiencke, and D. C. Christiani, “Association of cigarette smoking and asbestos exposure with location and histology of lung cancer,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 3, pp. 748–755, 1998. View at Google Scholar · View at Scopus
  112. L. Stayner, E. Kuempel, S. Gilbert, M. Hein, and J. Dement, “An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers,” Occupational and Environmental Medicine, vol. 65, no. 9, pp. 613–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. E. Yano, X. Wang, M. Wang, H. Qiu, and Z. Wang, “Lung cancer mortality from exposure to chrysotile asbestos and smoking: a case-control study within a cohort in China,” Occupational and Environmental Medicine, vol. 67, no. 12, pp. 867–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. M. J. Hein, L. T. Stayner, E. Lehman, and J. M. Dement, “Follow-up study of chrysotile textile workers: cohort mortality and exposure-response,” Occupational and Environmental Medicine, vol. 64, no. 9, pp. 616–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. R. Saracci, “Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction,” International Journal of Cancer, vol. 20, no. 3, pp. 323–331, 1977. View at Google Scholar · View at Scopus
  116. J. A. Talcott and K. H. Antman, “Asbestos-related malignancy,” Current Problems in Cancer, vol. 12, pp. 135–178, 1988. View at Google Scholar
  117. B. T. Mossman, “Mechanisms of asbestos carcinogenesis and toxicity: the amphibole hypothesis revisited,” British Journal of Industrial Medicine, vol. 50, no. 8, pp. 673–676, 1993. View at Google Scholar · View at Scopus
  118. S. Toyokuni, “Mechanisms of asbestos-induced carcinogenesis,” Nagoya Journal of Medical Science, vol. 71, no. 1-2, pp. 1–10, 2009. View at Google Scholar · View at Scopus
  119. Y. Nishimura, Y. Miura, M. Maeda et al., “Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 3, pp. 579–590, 2009. View at Google Scholar · View at Scopus
  120. E. Nena, P. Steiropoulos, T. C. Constantinidis, and D. Bouros, “Beyond pneumonoconiosis: recently described occupational interstitial lung diseases,” Pneumon, vol. 23, no. 3, pp. 297–300, 2010. View at Google Scholar · View at Scopus